tert-Butyl 1-oxo-3,6,9,12-tetraoxapentadecan-15-oate

Catalog No.: 
ACYKZG389
CAS No.: 
1415329-20-2
Molecular Formula: 
C15H28O7
Molecular Weight: 
320.38
tert-Butyl 1-oxo-3,6,9,12-tetraoxapentadecan-15-oate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%
5g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 1-oxo-3,6,9,12-tetraoxapentadecan-15-oate
IUPAC Nametert-butyl 1-oxo-3,6,9,12-tetraoxapentadecan-15-oate
MDL No.MFCD25424117
Molecular FormulaC15H28O7
Molecular Weight320.38
SMILESCC(C)(OC(CCOCCOCCOCCOCC=O)=O)C
InChI KeySCAAICMVIUVGGM-UHFFFAOYSA-N
SynonymCHO-PEG4-COOtBu;CHOCH2-PEG4-COOtBu;Ald-PEG4-t-butyl ester;Ald-CH2-PEG4-CH2CH2COOtBu;ALD-CH2-PEG4-T-BUTYL ESTER;Ald-CH2-PEG4-Boc;4,7,10,13-Tetraoxapentadecanoic acid, 15-oxo-, 1,1-dimethylethyl ester;tert-Butyl 1-oxo-3,6,9,12-tetraoxapentadecan-15-oate
CAS No.1415329-20-2
PubChem CID77078409

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACYKZG389 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUSDO214 route compound structure diagram
    ACUSDO214518044-32-1In Stock
  2. Then
  3. ACYKZG389 route product structure diagram
    ACYKZG3891415329-20-2In Stock
Inquiry

2. ACYKZG389 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOMRJ439 route compound structure diagram
    ACOMRJ439186020-66-6In Stock
  2. Then
  3. ACYKZG389 route product structure diagram
    ACYKZG3891415329-20-2In Stock
Inquiry

3. ACYKZG389 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYKZG389 route product structure diagram
    ACYKZG3891415329-20-2In Stock
Inquiry

Comments (0)